Latest On AMAG Pharmaceuticals, Inc (AMAG):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-11-25 11:14 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-13 03:10 EST | Earnings Estimate | An EPS average of $0.11 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-08 07:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-01 16:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-09 08:06 EST | Analyst Rating | The Analyst Target Price has increased from $11.43 to $11.96. | Neutral | |
| 2020-10-07 10:35 EST | News | Amag Pharma mulling options related to Makena withdrawal | N/A | |
| 2020-10-06 04:04 EST | News | FDA to yank approval for Amag Pharma's Makena; shares down 6% | N/A | |
| 2020-10-06 04:02 EST | News | FDA provides further update on Amag Pharma's Makena approval | N/A | |
| 2020-10-05 11:45 EST | Insider Trade | Capital Management LP Camber has indirectly disposed of 4,390,000 shares. | Sell | |
| 2020-10-05 04:07 EST | Analyst Rating | The Analyst Target Price has decreased from $11.45 to $11.43. | Sell | |
| 2020-10-03 08:07 EST | Analyst Rating | The Analyst Target Price has increased from $9.5 to $11.45. | Neutral | |
| 2020-10-02 13:18 EST | News | Covis takes out Amag Pharma for $498M | N/A | |
| 2020-10-01 04:36 EST | News | AMAG Pharma up 41% on takeover rumor | N/A | |
| 2020-09-26 04:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-19 04:05 EST | Analyst Rating | The Analyst Target Price has increased from $9.07 to $9.5. | Neutral | |
| 2020-08-10 00:05 EST | Analyst Rating | The Analyst Target Price has increased from $8.93 to $9.07. | Neutral | |
| 2020-08-09 08:49 EST | News | AMAG Pharmaceuticals, Inc. (AMAG) CEO Scott Myers on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-08 12:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 04:05 EST | Earnings Estimate | An EPS average of $0.02 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-08-07 04:05 EST | Analyst Rating | The Analyst Target Price has increased from $8.14 to $8.93. | Neutral | |
| 2020-08-06 20:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:15 EST | News | AMAG Pharmaceuticals EPS beats by $0.10, misses on revenue | N/A | |
| 2020-07-31 00:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 15:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:37 EST | News | Palatin Tech and Amag Pharma ax Vyleesi agreement | N/A | |
| 2020-07-23 19:29 EST | News | AMAG Pharma inks licensing deal for ciraparantag | N/A | |
| 2020-07-23 16:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 07:21 EST | News | AMAG Pharma's finance chief bids adieu | N/A | |
| 2020-06-04 18:37 EST | Insider Trade | DAVEY SCOON has directly acquired 10,269 shares and currently holds 43,898 shares. | Buy | |
| 2020-06-04 18:37 EST | Insider Trade | Kathrine O'Brien has directly acquired 10,269 shares and currently holds 18,949 shares. | Buy | |
| 2020-06-04 18:37 EST | Insider Trade | PAUL R. FONTEYNE has directly acquired 10,269 shares and currently holds 14,676 shares. | Buy | |
| 2020-06-04 18:37 EST | Insider Trade | JAMES R SULAT has directly acquired 10,269 shares and currently holds 35,090 shares. | Buy | |
| 2020-06-04 18:37 EST | Insider Trade | John A. Fallon has directly acquired 10,269 shares and currently holds 37,362 shares. | Buy | |
| 2020-06-04 18:37 EST | Insider Trade | GINO SANTINI has directly acquired 10,269 shares and currently holds 41,473 shares. | Buy | |
| 2020-06-04 18:37 EST | Insider Trade | Anne M. Phillips has directly acquired 10,269 shares and currently holds 18,949 shares. | Buy | |
| 2020-06-04 18:37 EST | Insider Trade | DAVID EDWARD JOHNSON has directly acquired 10,269 shares and currently holds 14,676 shares. | Buy | |
| 2020-06-02 00:06 EST | Analyst Rating | The Analyst Target Price has decreased from $8.81 to $8.14. | Neutral | |
| 2020-05-15 20:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-14 04:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-11 21:54 EST | News | AMAG Pharmaceuticals EPS misses by $0.23, beats on revenue | N/A | |
| 2020-05-11 21:52 EST | News | AMAG Pharmaceuticals, Inc. (AMAG) CEO Scott Myers on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-11 21:52 EST | News | AMAG Pharmaceuticals: Shedding Lackadaisical Segments And Management - Becoming A Focused, Undervalued Pure Play | N/A | |
| 2020-05-03 08:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 04:05 EST | Analyst Rating | The Analyst Target Price has decreased from $9.19 to $8.81. | Neutral | |
| 2020-04-29 12:05 EST | Analyst Rating | The Analyst Target Price has decreased from $9.31 to $9.19. | Neutral | |
| 2020-04-29 04:11 EST | News | AMAG Pharma gets its new CEO | N/A | |
| 2020-04-28 08:05 EST | Analyst Rating | The Analyst Target Price has increased from $9.19 to $9.31. | Buy | |
| 2020-04-24 04:05 EST | Analyst Rating | The Analyst Target Price has decreased from $9.31 to $9.19. | Neutral | |
| 2020-04-17 04:04 EST | Analyst Rating | The Analyst Target Price has decreased from $9.44 to $9.31. | Neutral | |
| 2020-04-11 01:41 EST | News | AMAG Pharmaceuticals EPS of -$5.89 | N/A | |
About AMAG Pharmaceuticals, Inc (AMAG):
AMAG Pharmaceuticals, Inc., a pharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and women's health, and anemia management in the United States. The company markets Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and Vyleesi (bremelanotide), an auto-injector device for the treatment of hypoactive sexual desire disorder in pre-menopausal women. Its product candidates also include AMAG-423 (ovine), an antibody fragment, which is in Phase 2b/3a trial for the treatment of severe preeclampsia in pregnant women; and Ciraparantag, an anticoagulant reversal agent that is in planned Phase 2b trial for the treatment of novel oral anticoagulants or low molecular weight heparin. The company sells Feraheme to authorized wholesalers and specialty distributors. The company has license agreements with Endoceutics, Inc., Palatin Technologies, Inc., Velo Bio, LLC, Prasco, LLC, Perosphere Pharmaceuticals Inc., and Antares Pharma, Inc. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts. As of November 12, 2020, AMAG Pharmaceuticals, Inc. operates as a subsidiary of Covis Group S.Ã r.l.
General
- Name AMAG Pharmaceuticals, Inc
- Symbol AMAG
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 440
- Last Split Factor3:2
- Last Split Date1991-09-26
- Fiscal Year EndDecember
- IPO Date1986-06-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.amagpharma.com
View More
Valuation
- Forward PE 30.58
- Price/Sales (Trailing 12 Mt.) 1.56
- Price/Book (Most Recent Quarter) 1.87
- Enterprise Value Revenue 2.06
View More
Financials
- Most Recent Quarter 2020-09-30
- Current Year EPS Estimate -$0.63
- Next Year EPS Estimate $0.38
- Next Quarter EPS Estimate $0.05
- Profit Margin -77%
- Operating Margin -14%
- Return on Assets -3%
- Revenue 300.12 million
- Earnings Per Share -$6.83
- Revenue Per Share $8.77
- Gross Profit 219.35 million
- Quarterly Earnings Growth 11.1%
View More
Highlights
- Market Capitalization 477.47 million
- EBITDA -55406000
- PEG Ratio 0.32
- Analyst Target Price $11.96
- Book Value Per Share $7.42
View More
Share Statistics
- Shares Outstanding 34.73 million
- Shares Float 23.47 million
- % Held by Insiders 229%
- % Held by Institutions 101.08%
- Shares Short 6.29 million
- Shares Short Prior Month 7.23 million
- Short Ratio 1.83
- Short % of Float 38%
- Short % of Shares Outstanding 18%
View More
Technicals
- Beta 0.87
- 52 Week High $13.77
- 52 Week Low $4.41
- 50 Day Moving Average 13.65
- 200 Day Moving Average 10.05
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
AMAG Pharmaceuticals, Inc (AMAG) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
AMAG Pharmaceuticals, Inc (AMAG) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-06 | $N/A | $1.19 | -$0.01 | 12000% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.23 | -$0.19 | -21.05% |
| 2020-03-31 | 2020-05-11 | $68.66 million | -$0.30 | -$0.03 | -900% |
| 2019-12-31 | 2020-03-04 | $89.71 million | -$0.35 | -$0.35 | 0% |
| 2019-09-30 | 2019-11-01 | $84.13 million | -$0.42 | -$0.66 | 36.36% |
| 2019-06-30 | 2019-08-07 | $78.11 million | -$0.87 | -$0.57 | -52.63% |
| 2019-03-31 | 2019-05-07 | $75.8 million | -$0.90 | -$0.26 | -246.15% |
| 2018-12-31 | 2019-02-07 | $88.12 million | -$0.60 | -$0.88 | 31.82% |
| 2018-09-30 | 2018-11-01 | $122.24 million | -$1.88 | -$0.79 | -137.97% |
| 2018-06-30 | 2018-08-02 | $146.25 million | -$0.75 | $0.26 | -388.46% |
| 2018-03-31 | 2018-05-03 | $146.36 million | -$1.59 | -$0.04 | -3875% |
| 2017-12-31 | 2018-02-27 | $158.34 million | $0.10 | $0.09 | 11.11% |
| 2017-09-30 | 2017-11-02 | $153.74 million | -$4.31 | $0.52 | -928.85% |
| 2017-06-30 | 2017-08-03 | $158.39 million | -$0.40 | $0.91 | -143.96% |
| 2017-03-31 | 2017-05-02 | $139.47 million | -$1.06 | $1.50 | -170.67% |
| 2016-12-31 | 2017-02-14 | $151.59 million | $1.85 | $1.89 | -2.12% |
| 2016-09-30 | 2016-11-03 | $143.78 million | $1.78 | $1.50 | 18.67% |
| 2016-06-30 | 2016-08-09 | $127.42 million | $1.45 | $1.20 | 20.83% |
| 2016-03-31 | 2016-05-03 | $109.3 million | $0.94 | $1.11 | -15.32% |
| 2015-12-31 | 2016-02-17 | $108.74 million | $1.12 | $1.16 | -3.45% |
| 2015-09-30 | 2015-11-03 | $96.15 million | $1.02 | $1.21 | -15.7% |
| 2015-06-30 | 2015-07-23 | $123.88 million | $1.12 | $1.13 | -0.89% |
| 2015-03-31 | 2015-05-05 | $89.51 million | $1.17 | $0.88 | 32.95% |
| 2014-12-31 | 2015-02-09 | $53.25 million | $4.67 | $0.30 | 1456.67% |
| 2014-09-30 | 2014-10-30 | $25.49 million | $0.06 | -$0.08 | 175% |
| 2014-06-30 | 2014-07-29 | $24.8 million | -$0.07 | -$0.09 | 22.22% |
| 2014-03-31 | 2014-04-24 | $20.84 million | -$0.33 | -$0.06 | -450% |
| 2013-12-31 | 2014-02-06 | $21.71 million | -$0.17 | -$0.10 | -70% |
| 2013-09-30 | 2013-10-23 | $21.62 million | -$0.01 | -$0.12 | 91.67% |
| 2013-06-30 | 2013-08-01 | $19.65 million | -$0.09 | -$0.16 | 43.75% |
| 2013-03-31 | 2013-04-23 | $17.88 million | -$0.19 | -$0.21 | 9.52% |
| 2012-12-31 | 2013-03-01 | $21.14 million | -$0.17 | -$0.06 | -183.33% |
| 2012-09-30 | 2012-11-01 | $17.74 million | -$0.19 | -$0.26 | 26.92% |
| 2012-06-30 | 2012-07-26 | $31.01 million | $0.14 | -$0.31 | 145.16% |
| 2012-03-31 | 2012-05-01 | $15.48 million | -$0.58 | -$0.63 | 7.94% |
| 2011-12-31 | 2012-03-05 | $14.91 million | -$0.87 | -$1.11 | 21.62% |
| 2011-09-30 | 2011-11-04 | $17.56 million | -$0.70 | -$1.00 | 30% |
| 2011-06-30 | 2011-07-26 | $15.4 million | -$0.92 | -$1.05 | 12.38% |
| 2011-03-31 | 2011-05-03 | $13.39 million | -$1.05 | -$1.02 | -2.94% |
| 2010-12-31 | 2011-02-25 | $17.22 million | -$0.83 | -$1.04 | 20.19% |
| 2010-09-30 | 2010-10-28 | $16.89 million | -$0.81 | -$1.10 | 26.36% |
| 2010-06-30 | 2010-07-28 | $18.83 million | -$1.01 | -$0.96 | -5.21% |
| 2010-03-31 | 2010-04-27 | $13.31 million | -$1.15 | -$0.85 | -35.29% |
| 2009-12-31 | 2010-03-01 | $13.15 million | -$1.07 | -$1.08 | 0.93% |
| 2009-09-30 | 2009-10-29 | $3.02 million | -$1.29 | -$1.47 | 12.24% |
| 2009-06-30 | 2009-07-29 | $55000 | -$1.55 | -$1.55 | 0% |
| 2009-03-31 | 2009-04-30 | $956000 | -$1.55 | -$1.30 | -19.23% |
| 2008-12-31 | 2009-02-27 | $580000 | -$1.28 | -$1.45 | 11.72% |
| 2008-09-30 | 2008-11-03 | $260000 | -$1.39 | -$1.14 | -21.93% |
| 2008-06-30 | 2008-07-29 | $486000 | -$1.00 | -$0.65 | -53.85% |
| 2008-03-31 | 2008-04-25 | $612000 | -$0.55 | -$0.61 | 9.84% |
| 2007-12-31 | 2008-02-21 | $391000 | -$0.57 | -$0.49 | -16.33% |
| 2007-09-30 | 2007-10-25 | $503000 | -$0.42 | -$0.44 | 4.55% |
| 2007-06-30 | 2007-07-25 | $746000 | -$0.46 | -$0.60 | 23.33% |
| 2007-03-31 | 2007-04-25 | $912000 | -$0.72 | -$0.58 | -24.14% |
| 2006-12-31 | 2007-01-24 | -$0.60 | -$0.50 | -20% | |
| 2006-09-30 | 2006-11-20 | $350000 | -$0.78 | -$0.53 | -47.17% |
| 2006-06-30 | 2006-07-20 | $945000 | -$0.57 | -$0.52 | -9.62% |
| 2006-03-31 | 2006-04-20 | $714000 | -$0.50 | -$0.36 | -38.89% |
| 2005-12-31 | 2006-01-19 | $664000 | -$0.43 | -$0.36 | -19.44% |
| 2005-09-30 | 2005-11-16 | $407000 | -$0.36 | -$0.35 | -2.86% |
| 2005-06-30 | 2005-07-19 | $403000 | -$0.38 | -$0.44 | 13.64% |
| 2005-03-31 | 2005-04-19 | $613000 | -$0.42 | -$0.42 | 0% |
| 2004-12-31 | 2005-01-18 | $1.02 million | -$0.32 | -$0.34 | 5.88% |
| 2004-09-30 | 2004-11-10 | $884000 | -$0.28 | -$0.26 | -7.69% |
| 2004-06-30 | 2004-07-18 | $1.47 million | -$0.10 | ||
| 2004-03-31 | 2004-04-16 | $766000 | -$0.07 | ||
| 2003-12-31 | 2004-01-16 | $632000 | -$0.12 | ||
| 2003-09-30 | 2003-11-09 | $778000 | $0.15 | ||
| 2003-06-30 | 2003-07-18 | $1.43 million | $0.10 | ||
| 2003-03-31 | 2003-05-13 | $1.01 million | -$0.10 | ||
| 2002-12-31 | 2002-12-31 | $1.56 million | -$0.05 | ||
| 2002-09-30 | 2002-09-30 | $1.03 million | -$0.36 | ||
| 2002-06-30 | 2002-06-30 | $1.14 million | -$0.02 | ||
| 2002-03-31 | 2002-03-31 | $2.05 million | $0.06 | ||
| 2001-12-31 | 2001-12-31 | $1.5 million | $0.06 | ||
| 2001-09-30 | 2001-09-30 | $1.74 million | $0.02 | ||
| 2001-06-30 | 2001-06-30 | $1.47 million | $0.11 | ||
| 2001-03-31 | 2001-03-31 | $1.21 million | $0.08 | ||
| 2000-12-31 | 2000-12-31 | $1.55 million | -$0.08 | ||
| 2000-06-30 | 2000-06-30 | $1 million | -$0.09 | ||
| 2000-03-31 | 2000-03-31 | $701000 | -$0.15 | ||
| 1999-12-31 | 1999-12-31 | -$0.21 | |||
| 1999-06-30 | 1999-06-30 | -$0.35 | |||
| 1999-03-31 | 1999-03-31 | -$0.12 | |||
| 1998-12-31 | 1998-12-31 | -$0.39 | |||
| 1997-09-30 | 1997-11-07 | -$0.30 | -$0.04 | -650% | |
| 1997-06-30 | 1997-07-16 | -$0.08 | $0.04 | -300% | |
| 1997-03-31 | 1997-04-15 | -$0.16 | -$0.08 | -100% | |
| 1996-12-31 | 1997-01-21 | $0.63 | $0.34 | 85.29% | |
| 1996-09-30 | 1996-11-06 | -$0.37 | -$0.31 | -19.35% | |
| 1996-06-30 | 1996-07-16 | -$0.42 | -$0.24 | -75% | |
| 1996-03-31 | 1996-04-17 | -$0.36 | -$0.22 | -63.64% | |
| 1995-12-31 | 1996-01-17 | -$0.28 | $0.33 | -184.85% | |
| 1994-09-30 | 1994-11-04 | -$0.35 | -$0.04 | -775% | |
| 1994-06-30 | 1994-07-18 | $0.13 | -$0.04 | 425% | |
| 1994-03-31 | 1994-04-13 | $0.05 | $0.00 | ||
| 1993-12-31 | 1994-01-14 | -$0.05 | $0.01 | -600% | |
| 1993-09-30 | 1993-11-05 | -$0.12 | -$0.03 | -300% | |
| 1993-06-30 | 1993-07-19 | -$0.24 | $0.01 | -2500% | |
| 1993-03-31 | 1993-04-20 | $0.00 | -$0.04 | 100% | |
| 1992-12-31 | 1993-01-16 | $0.01 | -$0.04 | 125% |
AMAG Pharmaceuticals, Inc (AMAG) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 11.18 million | 7.58 million | N/A |
| Income Before Tax | N/A | N/A | -24.39 million | -199.95 million | -23.39 million |
| Selling General Administrative | N/A | N/A | 52.7 million | 69.13 million | 65.72 million |
| Gross Profit | N/A | N/A | 44.3 million | 32.62 million | 47.7 million |
| Ebit | N/A | N/A | -7.84 million | -44.09 million | -18.02 million |
| Operating Income | N/A | N/A | -19.58 million | -44.09 million | -18.02 million |
| Income Tax Expense | -53000 | -160000 | N/A | -21000 | 232000 |
| Total Revenue | N/A | N/A | 68.66 million | 89.71 million | 84.13 million |
| Cost of Revenue | N/A | N/A | 24.36 million | 57.09 million | 36.44 million |
| Total Other Income Expense Net | N/A | N/A | 1.31 million | -155.86 million | -5.37 million |
| Net Income From Continuing Operations | N/A | N/A | -24.39 million | -199.93 million | -23.62 million |
| Net Income Applicable to Common Shares | 9.7 million | -13.24 million | -24.49 million | -199.93 million | -23.62 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | 13 million | 38.9 million |
| Change to Liabilities | 5.42 million | -33.82 million | N/A | -6.64 million | 17.61 million |
| Total Cash Flow from Investing Activities | -37.31 million | 39.66 million | -10.72 million | 12.55 million | -21.29 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | -1.23 million | 620000 | -92000 |
| Change to Operating Activities | -4.26 million | 3.66 million | N/A | 21.12 million | -18.76 million |
| Change in Cash | N/A | N/A | -58.55 million | -6.79 million | -30.66 million |
| Total Cash from Operating Activities | 36.68 million | 3.89 million | -46.61 million | -19.97 million | -9.28 million |
| Depreciation | N/A | N/A | 10.32 million | 4.19 million | 4.78 million |
| Other Cash Flow from Investing Activities | N/A | N/A | -10.65 million | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | -12.43 million | -3.5 million |
| Change to Account Receivables | N/A | N/A | N/A | -16.59 million | 5.6 million |
| Other Cash Flow from Financing Activities | N/A | N/A | -1.23 million | -22000 | -23000 |
| Change to Net Income | 26.65 million | -11.33 million | N/A | 177.14 million | 4.79 million |
| Capital Expenditures | N/A | N/A | 68000 | 446000 | 191000 |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 489.84 million | 505.11 million | 485.98 million |
| Total Stockholder Equity | N/A | N/A | 263.74 million | 286.12 million | 480.63 million |
| Other Current Liabilities | 2.48 million | N/A | N/A | 814000 | 2.44 million |
| Total Assets | N/A | N/A | 753.58 million | 791.23 million | 966.61 million |
| Common Stock | 345000 | 344000 | 342000 | 339000 | 339000 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -1.05 billion | -1.05 billion | -1.03 billion | -1.01 billion | -808.97 million |
| Other Liabilities | 8.3 million | 828000 | N/A | 89000 | 5.44 million |
| Other Assets | 3.02 million | 495000 | 495000 | 1.13 million | 1.13 million |
| Cash | N/A | N/A | 54.46 million | 113.01 million | 119.8 million |
| Total Current Liabilities | 161.98 million | N/A | 188.25 million | 208.19 million | 204.07 million |
| Other Stockholder Equity | -3.07 million | -2.96 million | -3.79 million | -3.24 million | -3.2 million |
| Property, Plant & Equipment | 23.48 million | 25.04 million | 26.15 million | 27.4 million | 14.55 million |
| Total Current Assets | 283.37 million | N/A | 290.64 million | 316.57 million | 340.84 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -168.46 million | -177.14 million | N/A | -160.01 million | -129.46 million |
| Short Term Investments | N/A | N/A | 70.29 million | 58.74 million | 71.74 million |
| Long Term Debt | N/A | N/A | 281.04 million | 277.03 million | 273.12 million |
| Inventory | 22.91 million | N/A | 33.68 million | 31.55 million | 28.64 million |
| Accounts Payable | 9.74 million | N/A | 16.52 million | 27.02 million | 26.55 million |
AMAG Pharmaceuticals, Inc (AMAG) Chart:
AMAG Pharmaceuticals, Inc (AMAG) News:
Below you will find a list of latest news for AMAG Pharmaceuticals, Inc (AMAG) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
AMAG Pharmaceuticals, Inc (AMAG) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
AMAG Pharmaceuticals, Inc (AMAG) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000066/0000792977-20-000066-index.htm |
| 2019-09-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/792977/000000000019013610/0000000000-19-013610-index.htm |
| 2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000009375120000337/0000093751-20-000337-index.htm |
| 2020-01-31 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000076999320000081/0000769993-20-000081-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000043/0000792977-19-000043-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000044/0000792977-19-000044-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000045/0000792977-19-000045-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000046/0000792977-19-000046-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000047/0000792977-19-000047-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000048/0000792977-19-000048-index.htm |
| 2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000050/0000792977-19-000050-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000052/0000792977-19-000052-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000056/0000792977-19-000056-index.htm |
| 2019-04-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000065/0000792977-19-000065-index.htm |
| 2019-04-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000068/0000792977-19-000068-index.htm |
| 2019-04-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000070/0000792977-19-000070-index.htm |
| 2019-04-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000072/0000792977-19-000072-index.htm |
| 2019-04-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000074/0000792977-19-000074-index.htm |
| 2019-04-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000075/0000792977-19-000075-index.htm |
| 2019-04-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/792977/000079297719000077/0000792977-19-000077-index.htm |
| 2019-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000079/0000792977-19-000079-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000081/0000792977-19-000081-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/792977/000079297719000084/0000792977-19-000084-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000087/0000792977-19-000087-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000088/0000792977-19-000088-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000091/0000792977-19-000091-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000102/0000792977-19-000102-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000103/0000792977-19-000103-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000104/0000792977-19-000104-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000105/0000792977-19-000105-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000106/0000792977-19-000106-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000107/0000792977-19-000107-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000108/0000792977-19-000108-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000109/0000792977-19-000109-index.htm |
| 2019-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000111/0000792977-19-000111-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000113/0000792977-19-000113-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000116/0000792977-19-000116-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000119/0000792977-19-000119-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/792977/000079297719000121/0000792977-19-000121-index.htm |
| 2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000124/0000792977-19-000124-index.htm |
| 2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000127/0000792977-19-000127-index.htm |
| 2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297719000128/0000792977-19-000128-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000131/0000792977-19-000131-index.htm |
| 2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000134/0000792977-19-000134-index.htm |
| 2019-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/792977/000079297719000137/0000792977-19-000137-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297719000140/0000792977-19-000140-index.htm |
| 2020-01-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000004/0000792977-20-000004-index.htm |
| 2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000009/0000792977-20-000009-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000016/0000792977-20-000016-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000017/0000792977-20-000017-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000018/0000792977-20-000018-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000019/0000792977-20-000019-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000020/0000792977-20-000020-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000021/0000792977-20-000021-index.htm |
| 2020-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/792977/000079297720000027/0000792977-20-000027-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000030/0000792977-20-000030-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000031/0000792977-20-000031-index.htm |
| 2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000033/0000792977-20-000033-index.htm |
| 2020-04-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000036/0000792977-20-000036-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000037/0000792977-20-000037-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000042/0000792977-20-000042-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/792977/000079297720000043/0000792977-20-000043-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000045/0000792977-20-000045-index.htm |
| 2020-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000048/0000792977-20-000048-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000056/0000792977-20-000056-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000057/0000792977-20-000057-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000058/0000792977-20-000058-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000059/0000792977-20-000059-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000060/0000792977-20-000060-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000061/0000792977-20-000061-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000062/0000792977-20-000062-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000064/0000792977-20-000064-index.htm |
| 2020-06-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000066/0000792977-20-000066-index.htm |
| 2020-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000068/0000792977-20-000068-index.htm |
| 2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000070/0000792977-20-000070-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000072/0000792977-20-000072-index.htm |
| 2020-08-11 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/792977/000079297720000075/0000792977-20-000075-index.htm |
| 2020-08-17 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/792977/000079297720000080/0000792977-20-000080-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000081/0000792977-20-000081-index.htm |
| 2020-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000079297720000083/0000792977-20-000083-index.htm |
| 2020-09-15 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/792977/000079297720000090/0000792977-20-000090-index.htm |
| 2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000079297720000092/0000792977-20-000092-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/792977/000079297720000094/0000792977-20-000094-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000083423720001671/0000834237-20-001671-index.htm |
| 2019-08-15 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/792977/000090266419003418/0000902664-19-003418-index.htm |
| 2019-08-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000090266419003419/0000902664-19-003419-index.htm |
| 2019-09-04 | PREC14A | Preliminary proxy statements, contested solicitations | https://www.sec.gov/Archives/edgar/data/792977/000090266419003607/0000902664-19-003607-index.htm |
| 2019-09-04 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/792977/000090266419003608/0000902664-19-003608-index.htm |
| 2019-09-04 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000090266419003609/0000902664-19-003609-index.htm |
| 2019-09-16 | DEFC14A | Definitive proxy statement, contested solicitations | https://www.sec.gov/Archives/edgar/data/792977/000090266419003717/0000902664-19-003717-index.htm |
| 2019-09-16 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000090266419003718/0000902664-19-003718-index.htm |
| 2019-09-16 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000090266419003736/0000902664-19-003736-index.htm |
| 2019-09-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000090266419003738/0000902664-19-003738-index.htm |
| 2019-09-26 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000090266419003829/0000902664-19-003829-index.htm |
| 2019-09-26 | DFRN14A | Revised definitive proxy statement filed by non-management | https://www.sec.gov/Archives/edgar/data/792977/000090266419003831/0000902664-19-003831-index.htm |
| 2019-10-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/792977/000090266419003959/0000902664-19-003959-index.htm |
| 2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000090266419003962/0000902664-19-003962-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000090266420002288/0000902664-20-002288-index.htm |
| 2019-05-20 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000091957419003784/0000919574-19-003784-index.htm |
| 2019-06-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000091957419004320/0000919574-19-004320-index.htm |
| 2019-06-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000091957419004322/0000919574-19-004322-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000091957420001490/0000919574-20-001490-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000091957420002015/0000919574-20-002015-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000091957420002488/0000919574-20-002488-index.htm |
| 2020-10-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000091957420006223/0000919574-20-006223-index.htm |
| 2020-10-01 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/792977/000095014220002337/0000950142-20-002337-index.htm |
| 2020-10-13 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/792977/000095014220002399/0000950142-20-002399-index.htm |
| 2020-10-26 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/792977/000095014220002432/0000950142-20-002432-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000103738920000005/0001037389-20-000005-index.htm |
| 2020-04-15 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/792977/000104746920002313/0001047469-20-002313-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/792977/000104746920002674/0001047469-20-002674-index.htm |
| 2019-04-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465919020170/0001104659-19-020170-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465919020171/0001104659-19-020171-index.htm |
| 2019-05-16 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/792977/000110465919030015/0001104659-19-030015-index.htm |
| 2019-09-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000110465919048745/0001104659-19-048745-index.htm |
| 2019-09-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000110465919048805/0001104659-19-048805-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000110465920018256/0001104659-20-018256-index.htm |
| 2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000110465920028904/0001104659-20-028904-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920029288/0001104659-20-029288-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920029290/0001104659-20-029290-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920029291/0001104659-20-029291-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920029292/0001104659-20-029292-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920029295/0001104659-20-029295-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920029296/0001104659-20-029296-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920032482/0001104659-20-032482-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920032483/0001104659-20-032483-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920032485/0001104659-20-032485-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000110465920032487/0001104659-20-032487-index.htm |
| 2020-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000110465920047191/0001104659-20-047191-index.htm |
| 2020-09-15 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/792977/000110465920105287/0001104659-20-105287-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000110465920111126/0001104659-20-111126-index.htm |
| 2020-10-01 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/792977/000110465920111160/0001104659-20-111160-index.htm |
| 2020-10-01 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/792977/000110465920111163/0001104659-20-111163-index.htm |
| 2020-10-13 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/792977/000110465920114090/0001104659-20-114090-index.htm |
| 2020-10-13 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/792977/000110465920114549/0001104659-20-114549-index.htm |
| 2020-10-15 | SC 14D9 | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/792977/000110465920115117/0001104659-20-115117-index.htm |
| 2020-10-26 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/792977/000110465920117995/0001104659-20-117995-index.htm |
| 2020-11-06 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/792977/000110465920122184/0001104659-20-122184-index.htm |
| 2019-04-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000114420419018629/0001144204-19-018629-index.htm |
| 2020-10-15 | SC TO-T | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/792977/000119312520269800/0001193125-20-269800-index.htm |
| 2019-09-10 | PREC14A | Preliminary proxy statements, contested solicitations | https://www.sec.gov/Archives/edgar/data/792977/000121390019017568/0001213900-19-017568-index.htm |
| 2019-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000121390019017826/0001213900-19-017826-index.htm |
| 2019-09-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000121390019017828/0001213900-19-017828-index.htm |
| 2019-09-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/792977/000121390019018069/0001213900-19-018069-index.htm |
| 2019-09-16 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/792977/000121390019018070/0001213900-19-018070-index.htm |
| 2019-09-20 | DEFC14A | Definitive proxy statement, contested solicitations | https://www.sec.gov/Archives/edgar/data/792977/000121390019018487/0001213900-19-018487-index.htm |
| 2019-09-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000121390019018617/0001213900-19-018617-index.htm |
| 2019-10-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000121390019019736/0001213900-19-019736-index.htm |
| 2019-10-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/792977/000121390019019941/0001213900-19-019941-index.htm |
| 2019-10-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/792977/000121390019019951/0001213900-19-019951-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000130692320000005/0001306923-20-000005-index.htm |
| 2019-07-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000165495419008570/0001654954-19-008570-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm |
| 2019-09-20 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/792977/000165495419010958/0001654954-19-010958-index.htm |
| 2019-10-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/792977/000165495419011730/0001654954-19-011730-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/792977/000165495420010821/0001654954-20-010821-index.htm |
| 2020-05-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/792977/999999999720002556/9999999997-20-002556-index.htm |
| 2020-05-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/792977/999999999720002557/9999999997-20-002557-index.htm |
| 2020-05-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/792977/999999999720002558/9999999997-20-002558-index.htm |
| 2020-05-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/792977/999999999720002559/9999999997-20-002559-index.htm |
AMAG Pharmaceuticals, Inc (AMAG) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AMAG Pharmaceuticals, Inc (AMAG). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 229%Institutional Ownership: 10108%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-01 | Capital Management LP Camber | 10% Share Holder | Sell | 4,390,000.00 | 13.57 | 59,586,787.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/792977/000165495420010821/0001654954-20-010821-index.htm |
| 2020-06-02 | DAVID EDWARD JOHNSON | Director | Buy | 10,269.00 | 14,676.00 | https://www.sec.gov/Archives/edgar/data/792977/000090266420002288/0000902664-20-002288-index.htm | ||
| 2020-06-02 | PAUL R. FONTEYNE | Director | Buy | 10,269.00 | 14,676.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297720000058/0000792977-20-000058-index.htm | ||
| 2019-06-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 25,000.00 | 8.85 | 221,250.00 | 150,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm |
| 2019-06-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 30,000.00 | 8.86 | 265,800.00 | 180,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm |
| 2020-06-02 | Anne M. Phillips | Director | Buy | 10,269.00 | 18,949.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297720000062/0000792977-20-000062-index.htm | ||
| 2020-06-02 | Kathrine O'Brien | Director | Buy | 10,269.00 | 18,949.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297720000057/0000792977-20-000057-index.htm | ||
| 2019-06-27 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 20,000.00 | 9.47 | 189,400.00 | 200,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm |
| 2019-08-07 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 40,000.00 | 7.43 | 297,200.00 | 240,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm |
| 2019-05-16 | JAMES R SULAT | Director | Buy | 8,116.00 | 24,821.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000106/0000792977-19-000106-index.htm | ||
| 2019-05-16 | Barbara Deptula | Director | Buy | 8,116.00 | 26,354.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000109/0000792977-19-000109-index.htm | ||
| 2019-05-16 | John A. Fallon | Director | Buy | 8,116.00 | 27,093.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000104/0000792977-19-000104-index.htm | ||
| 2020-01-24 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 40,000.00 | 9.72 | 388,800.00 | 280,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm |
| 2020-03-10 | Kelly Schick | Chief Human Resources Officer | Buy | 13,000.00 | 28,234.00 | https://www.sec.gov/Archives/edgar/data/792977/000110465920032485/0001104659-20-032485-index.htm | ||
| 2020-01-27 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 8,000.00 | 9.41 | 75,280.00 | 288,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm |
| 2019-05-16 | ROBERT J PEREZ | Director | Buy | 8,116.00 | 29,229.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000107/0000792977-19-000107-index.htm | ||
| 2020-02-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 24,000.00 | 8.29 | 198,960.00 | 312,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420002015/0000919574-20-002015-index.htm |
| 2019-05-16 | GINO SANTINI | Director | Buy | 8,116.00 | 31,204.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000108/0000792977-19-000108-index.htm | ||
| 2020-02-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 12,000.00 | 8.29 | 99,480.00 | 324,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420002015/0000919574-20-002015-index.htm |
| 2019-05-16 | DAVEY SCOON | Director | Buy | 8,116.00 | 33,629.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000102/0000792977-19-000102-index.htm | ||
| 2020-03-16 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 24,000.00 | 4.87 | 116,880.00 | 348,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420002488/0000919574-20-002488-index.htm |
| 2020-06-02 | JAMES R SULAT | Director | Buy | 10,269.00 | 35,090.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297720000059/0000792977-20-000059-index.htm | ||
| 2019-06-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 3,636,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm | ||
| 2019-06-25 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 259,016.00 | 8.59 | 2,224,947.44 | 3,636,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm |
| 2020-06-02 | John A. Fallon | Director | Buy | 10,269.00 | 37,362.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297720000060/0000792977-20-000060-index.htm | ||
| 2019-06-26 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 3,756,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm | ||
| 2019-06-26 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 120,000.00 | 9.13 | 1,095,600.00 | 3,756,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm |
| 2019-06-27 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 3,800,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm | ||
| 2019-06-27 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 44,000.00 | 9.52 | 418,880.00 | 3,800,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm |
| 2020-01-09 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 4,047,534.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm | ||
| 2020-01-09 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 12,466.00 | 12.43 | 154,952.38 | 4,047,534.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm |
| 2019-08-07 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 4,060,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm | ||
| 2019-08-07 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 260,000.00 | 7.32 | 1,903,200.00 | 4,060,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm |
| 2020-01-09 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 4,060,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm | ||
| 2020-01-09 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 12,466.00 | 12.33 | 153,705.78 | 4,060,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm |
| 2020-01-10 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 4,078,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm | ||
| 2020-01-10 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 18,000.00 | 11.64 | 209,520.00 | 4,078,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm |
| 2020-01-24 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 4,112,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm | ||
| 2020-01-24 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 34,000.00 | 9.58 | 325,720.00 | 4,112,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm |
| 2020-01-27 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 4,120,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm | ||
| 2020-01-27 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 8,000.00 | 9.43 | 75,440.00 | 4,120,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm |
| 2020-06-02 | GINO SANTINI | Director | Buy | 10,269.00 | 41,473.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297720000061/0000792977-20-000061-index.htm | ||
| 2019-08-07 | Capital Management LP Camber | 10% Share Holder | Buy | 301,000.00 | 7.79 | 2,343,495.70 | 4,306,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm |
| 2019-08-07 | Capital Management LP Camber | 10% Share Holder | Buy | 50,000.00 | 7.74 | 387,000.00 | 4,356,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm |
| 2019-08-07 | Capital Management LP Camber | 10% Share Holder | Buy | 4,000.00 | 7.58 | 30,300.00 | 4,360,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm |
| 2019-08-09 | Capital Management LP Camber | 10% Share Holder | Buy | 26,600.00 | 8.94 | 237,790.70 | 4,386,600.00 | https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm |
| 2020-06-02 | DAVEY SCOON | Director | Buy | 10,269.00 | 43,898.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297720000056/0000792977-20-000056-index.htm | ||
| 2019-08-09 | Capital Management LP Camber | 10% Share Holder | Buy | 3,400.00 | 9.18 | 31,205.54 | 4,390,000.00 | https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm |
| 2019-10-08 | DAVID EDWARD JOHNSON | Director | Buy | 4,407.00 | 4,407.00 | https://www.sec.gov/Archives/edgar/data/792977/000090266419003962/0000902664-19-003962-index.htm | ||
| 2019-10-08 | PAUL R. FONTEYNE | Director | Buy | 4,407.00 | 4,407.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000128/0000792977-19-000128-index.htm | ||
| 2019-05-09 | WILLIAM K HEIDEN | President & CEO | Buy | 10,000.00 | 10.70 | 107,000.00 | 490,056.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000088/0000792977-19-000088-index.htm |
| 2019-04-10 | Anne M. Phillips | Director | Buy | 564.00 | 564.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000075/0000792977-19-000075-index.htm | ||
| 2019-04-10 | Kathrine O'Brien | Director | Buy | 564.00 | 564.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000070/0000792977-19-000070-index.htm | ||
| 2019-04-04 | Anthony Casciano | Chief Commercial Officer | Buy | 15,000.00 | 60,852.00 | https://www.sec.gov/Archives/edgar/data/792977/000110465919020171/0001104659-19-020171-index.htm | ||
| 2019-05-09 | Elizabeth Scott Bolgiano | Chief Human Resources Officer | Buy | 5,000.00 | 10.93 | 54,650.00 | 74,847.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000087/0000792977-19-000087-index.htm |
| 2020-03-10 | Anthony Casciano | Chief Commercial Officer | Buy | 25,000.00 | 78,209.00 | https://www.sec.gov/Archives/edgar/data/792977/000110465920032482/0001104659-20-032482-index.htm | ||
| 2019-03-07 | Joseph Vittiglio | EVP, General Counsel | Sell | 1,425.00 | 14.01 | 19,964.25 | 78,955.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000052/0000792977-19-000052-index.htm |
| 2019-05-28 | Julie Krop | Chief Medical Officer | Buy | 10,000.00 | 9.91 | 99,100.00 | 81,399.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000113/0000792977-19-000113-index.htm |
| 2019-05-16 | Anne M. Phillips | Director | Buy | 8,116.00 | 8,680.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000105/0000792977-19-000105-index.htm | ||
| 2019-05-16 | Kathrine O'Brien | Director | Buy | 8,116.00 | 8,680.00 | https://www.sec.gov/Archives/edgar/data/792977/000079297719000103/0000792977-19-000103-index.htm | ||
| 2020-03-10 | Joseph Vittiglio | CBO, General Counsel | Buy | 25,000.00 | 92,244.00 | https://www.sec.gov/Archives/edgar/data/792977/000110465920032483/0001104659-20-032483-index.htm | ||
| 2020-03-10 | Edward H Myles | COO & CFO | Buy | 30,000.00 | 98,659.00 | https://www.sec.gov/Archives/edgar/data/792977/000110465920032487/0001104659-20-032487-index.htm |